Nicotine pharmacodynamics with a new oral nicotine replacement product and NiQuitin Lozenge. A study in healthy smokers.

Registry ID
EUCTR2009-015870-36
Source registry
EUCTR
Status
Completed
Phase
PHASE2
Sponsor
McNeil AB
Start date
2009-12-22
Completion date
2010-05-19
Last update
2026-08-16

Conditions

Summary

The primary objectives of this study are: •to compare ONS (two sprays of 1 mg nicotine) and NiQuitin lozenge 2 mg after 5 hours of witnessed abstinence with respect to urges to smoke during the first 5 minutes after start of treatment., and •to compare ONS (two sprays of 1 mg nicotine) and NiQuitin lozenge 4 mg after 5 hours of witnessed abstinence with respect to urges to smoke during the first 5 minutes after start of treatment.

Locations

View on source registry